SCHEIN AND ETHICAL HOLDINGS IN $32 MIL. LICENSING AND DEVELOPMENT DEAL
Executive Summary
SCHEIN AND ETHICAL HOLDINGS IN $32 MIL. LICENSING AND DEVELOPMENT DEAL for the "development of a portfolio of oral controlled- release and/or transdermal products." With the Sept. 1 joint venture announcement, Florham Park, N.J.-based Schein moves into alternative drug delivery systems development with Godmanchester, England-based Ethical Holdings.